Redmond Asset Management’s Lantern Pharma LTRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $119K | Sell |
|
|||||
|
2024
Q3 | $143K | Sell |
|
|||||
|
2024
Q2 | $185K | Sell |
|
|||||
|
2024
Q1 | $356K | Sell |
|
|||||
|
2023
Q4 | $174K | Sell |
|
|||||
|
2023
Q3 | $159K | Sell |
|
|||||
|
2023
Q2 | $263K | Sell |
|
|||||
|
2023
Q1 | $238K | Sell |
|
|||||
|
2022
Q4 | $304K | Buy |
|
|||||
|
2022
Q3 | $237K | Sell |
|
|||||
|
2022
Q2 | $284K | Sell |
|
|||||
|
2022
Q1 | $356K | Buy |
|
|||||
|
2021
Q4 | $393K | Buy |
|
|||||
|
2021
Q3 | $530K | Buy |
|
|||||
|
2021
Q2 | $664K | Buy |
|
|||||
|
2021
Q1 | $816K | Buy |
|